Xinyi Solar Holdings Limited (HKG:0968)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 28.32B |
| Revenue (ttm) | 23.19B |
| Net Income (ttm) | -62.26M |
| Shares Out | 9.08B |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | 13.57 |
| Dividend | 0.10 (3.19%) |
| Ex-Dividend Date | Aug 13, 2024 |
| Volume | 62,019,964 |
| Average Volume | 134,215,922 |
| Open | 3.130 |
| Previous Close | 3.140 |
| Day's Range | 3.080 - 3.150 |
| 52-Week Range | 2.220 - 4.730 |
| Beta | 1.21 |
| RSI | 57.80 |
| Earnings Date | Jul 31, 2025 |
About Theseus Pharmaceuticals
Xinyi Solar Holdings Limited, an investment holding company, produces, sells, and trades in solar glass products in Mainland China, rest of Asia, North America, Europe, and internationally. It operates through two segments, Sales of Solar Glass and Solar Farm Business. The company offers ultra-clear patterned solar glasses, back glasses, and anti-reflective coating solar glasses. It also develops, operates, and manages solar farms; and generates solar power. In addition, the company offers engineering, procurement, and construction services; so... [Read more]
Financial Performance
In 2024, Xinyi Solar Holdings's revenue was 21.92 billion, a decrease of -9.28% compared to the previous year's 24.16 billion. Earnings were 1.01 billion, a decrease of -73.76%.
Financial StatementsNews
Hong Kong stocks take a breather ahead of Fed decision and earnings reports
Caution returned to Hong Kong stocks as the city’s benchmark fell from its highest point in three years, with investors gearing up for the US Federal Reserve’s rate decision and earnings reports. The ...